Larry Grace has more than 13 years of experience in both large biopharma (Amgen, Novartis) and venture (Generate Biomedicines) in operating roles spanning strategy, corporate development, portfolio management, and operations. He has led a wide variety of initiatives with senior leaderships to revolutionize biopharma R&D across therapeutic areas, from early discovery through clinical trial execution, often leading to a combination of internal and external investments. Areas of focus included current and emerging platforms and modalities, wet/dry lab cycle innovation, clinical trial design/execution, molecular diagnostics, regenerative medicine, and quantum computing.
Larry received a BS and MA from UC Berkeley in Nuclear Engineering and Biophysics, as well as an MBA and JD from Northwestern (Kellogg and Pritzker).